Cardiovascular Risks in Hemodialysis Patients

Chronic kidney disease requiring haemodialysis is accompanied by an exceptionally high burden of cardiovascular morbidity and mortality. Repeated fluctuations in intravascular volume and electrolytes, particularly potassium and calcium, impose haemodynamic stress that favours myocardial remodelling and left ventricular hypertrophy. Uraemic toxins, inflammation and endothelial dysfunction accelerate atherosclerosis and vascular calcification, further compromising coronary perfusion. Electrical instability arises from structural changes and rapid shifts in serum electrolytes across the dialysis cycle, predisposing to atrial fibrillation, ventricular tachycardia and sudden cardiac death. The length of the interdialytic interval, dialysate composition and individual patient factors interact to modulate arrhythmic risk. A comprehensive strategy that integrates personalised dialysis prescriptions, continuous monitoring and targeted interventions is therefore essential to mitigate cardiovascular complications in this population.

Research from Nature Portfolio

A novel non-invasive method has been developed to estimate serum potassium concentration directly from T-wave morphology in standard ECG recordings. By analysing the ratio of T-wave slope to amplitude using eigenlead techniques and validating against concurrent blood samples, the approach achieved a mean absolute error below 0.5 mM. Computational simulations linked the estimator to delayed-rectifier potassium currents, offering mechanistic insight. This innovation holds promise for real-time surveillance of hyperkalaemia and hypokalaemia without repeated phlebotomy, enabling earlier detection and prevention of arrhythmic episodes in haemodialysis patients.

Cardiovascular Risks in Hemodialysis Patients publication trend

The graph below shows the total number of articles in cardiovascular risks in hemodialysis patients across all publications each year (not limited to Nature Index journals).

Technical terms

Haemodialysis: Renal replacement therapy that removes waste products and excess fluid from the blood via a dialyser.

Arrhythmia: Any disturbance of the heart’s rhythm or rate, including atrial fibrillation and ventricular tachycardia.

Hyperkalaemia: Elevated serum potassium concentration, often defined as >5.5 mmol/L, which can precipitate life-threatening arrhythmias.

Hypokalaemia: Reduced serum potassium concentration, typically <3.5 mmol/L, increasing predisposition to electrical instability.

QTc interval: The heart’s repolarisation period corrected for heart rate; prolongation is a marker for ventricular arrhythmia risk.

References

1. Noninvasive quantification of blood potassium concentration from ECG in hemodialysis patients. Scientific Reports (2017).
2. Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia. Kidney International (2024).
3. Evaluation of a wearable biosensor to monitor potassium imbalance in patients receiving hemodialysis. Sensing and Bio-Sensing Research (2023).
4. Serum Potassium and Mortality Risk in Hemodialysis Patients: A Cohort Study. Kidney Medicine (2021).